FX.co ★ AngioDynamics Inc. Q2 Loss Decreases, Beats Estimates

AngioDynamics Inc. (ANGO) reported a reduced loss for the second quarter compared to the previous year, surpassing Wall Street expectations.

The company's net loss was $10.738 million, or $0.26 per share, an improvement from last year's second-quarter loss of $29.048 million, or $0.72 per share.

Excluding certain items, AngioDynamics posted an adjusted net loss of $1.742 million, or $0.04 per share, for this quarter.

Analysts, as surveyed by Thomson Reuters, had projected a loss of $0.11 per share, generally not factoring in special items.

Quarterly revenue decreased by 7.9% to $72.845 million from the previous year's $79.073 million.

A snapshot of AngioDynamics Inc.'s financials (GAAP) for the second quarter is as follows:

- Loss: $10.738 million compared to $29.048 million last year.

- Loss per Share: $0.26 compared to $0.72 last year.

- Revenue: $72.845 million compared to $79.073 million last year.